Mood disturbances, including irritability or depression
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Great fast service Down to my second month
Serious Health Concerns: While rare, GLP1's can lead to severe conditions like acute pancreatitis, acute kidney injury, and gallbladder disease
B12 Intravenoso: Applications in Acute Settings In urgent situations, like being in the hospital for a severe B12 deficiency or after some surgeries, IV B12 is very helpful
Suitability: Injections suit diagnosed deficiency